Published in Gut on September 01, 1999
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ (2008) 6.97
Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut (2007) 3.87
Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects. PLoS One (2015) 3.37
Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One (2010) 3.03
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut (2006) 2.82
Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol (2009) 2.39
A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut (2006) 2.33
A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation. Am J Gastroenterol (2012) 2.11
A randomised controlled trial of self-help interventions in patients with a primary care diagnosis of irritable bowel syndrome. Gut (2005) 2.11
British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut (2000) 2.09
Effect of cholecystectomy on bowel function: a prospective, controlled study. Gut (1999) 2.08
The epidemiology of irritable bowel syndrome. Clin Epidemiol (2014) 2.06
Non-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders. Neurogastroenterol Motil (2015) 1.99
Guidelines for the investigation of chronic diarrhoea, 2nd edition. Gut (2003) 1.98
Use and abuse of hydrogen breath tests. Gut (2006) 1.97
Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol (2008) 1.93
Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology (2006) 1.91
Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut (2007) 1.90
Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol (2011) 1.89
Laparoscopic ventral rectopexy: a prospective long-term evaluation of functional results and quality of life. Tech Coloproctol (2013) 1.84
The standardization of terminology for researchers in female pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct (2001) 1.82
Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut (2004) 1.76
Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol (2009) 1.76
Regional gray matter density changes in brains of patients with irritable bowel syndrome. Gastroenterology (2010) 1.75
Review of the treatment options for chronic constipation. MedGenMed (2007) 1.64
Prevalence of irritable bowel syndrome and depression in fibromyalgia. Dig Dis Sci (2006) 1.63
Constipation and risk of cardiovascular disease among postmenopausal women. Am J Med (2011) 1.63
Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut (2006) 1.60
Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut (2004) 1.59
Brain-gut-microbe communication in health and disease. Front Physiol (2011) 1.59
IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci (2004) 1.53
Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol (2008) 1.52
Role of infection in irritable bowel syndrome. J Gastroenterol (2007) 1.50
Diagnosis of neglected tropical diseases among patients with persistent digestive disorders (diarrhoea and/or abdominal pain ≥14 days): Pierrea multi-country, prospective, non-experimental case-control study. BMC Infect Dis (2015) 1.50
Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut (2004) 1.50
Increased expression of CCL20 in human inflammatory bowel disease. J Clin Immunol (2004) 1.50
Development of functional gastrointestinal disorders after Giardia lamblia infection. BMC Gastroenterol (2009) 1.48
Defecographic pelvic floor abnormalities in constipated patients: does mode of delivery matter? Tech Coloproctol (2009) 1.47
Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut (2002) 1.47
Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention. Aliment Pharmacol Ther (2012) 1.47
Prevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria. Patient Prefer Adherence (2008) 1.46
Patient and practitioner influences on the placebo effect in irritable bowel syndrome. Psychosom Med (2009) 1.43
Role of serotonin in the pathophysiology of the irritable bowel syndrome. Br J Pharmacol (2004) 1.43
Clinical outcome of laparoscopic antireflux surgery for patients with irritable bowel syndrome. Surg Endosc (2004) 1.43
Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol (2004) 1.42
Abdominal wall pain--classification, diagnosis and treatment suggestions. Wien Klin Wochenschr (2007) 1.41
Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil (2008) 1.41
Are the definitions for chronic diarrhoea adequate? Evaluation of two different definitions in patients with chronic diarrhoea. United European Gastroenterol J (2015) 1.40
Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Clin Gastroenterol Hepatol (2008) 1.39
Chronic pain, overweight, and obesity: findings from a community-based twin registry. J Pain (2010) 1.39
Acupuncture treatment in irritable bowel syndrome. Gut (2005) 1.37
Microscopic colitis: a retrospective study of clinical presentation in 53 patients. World J Gastroenterol (2005) 1.35
Association between early adverse life events and irritable bowel syndrome. Clin Gastroenterol Hepatol (2011) 1.35
Sodium channel mutation in irritable bowel syndrome: evidence for an ion channelopathy. Am J Physiol Gastrointest Liver Physiol (2008) 1.33
Childhood trauma is associated with hypothalamic-pituitary-adrenal axis responsiveness in irritable bowel syndrome. Gastroenterology (2009) 1.33
Familial aggregation of irritable bowel syndrome: a prospective study. Gut (2003) 1.33
Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol (2012) 1.32
The association of serotonin transporter genetic polymorphisms and irritable bowel syndrome and its influence on tegaserod treatment in Chinese patients. Dig Dis Sci (2007) 1.32
Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World J Gastroenterol (2010) 1.29
Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome? Am J Physiol Gastrointest Liver Physiol (2009) 1.24
Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent on the presence of methane gas: subanalysis of a double-blind randomized controlled study. Dig Dis Sci (2006) 1.24
The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III. J Neurogastroenterol Motil (2010) 1.24
Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol (2009) 1.19
Irritable bowel syndrome aggregates strongly in families: a family-based case-control study. Neurogastroenterol Motil (2008) 1.19
Abnormal endogenous pain modulation and somatic and visceral hypersensitivity in female patients with irritable bowel syndrome. World J Gastroenterol (2007) 1.17
Irritable bowel syndrome. Nat Rev Dis Prim (2016) 1.14
Anxiety, depression and quality of life in patients with irritable bowel syndrome. Gut Liver (2011) 1.12
Validation of the Japanese version of the Rome II modular questionnaire and irritable bowel syndrome severity index. J Gastroenterol (2006) 1.11
The evaluation of otilonium bromide treatment in asian patients with irritable bowel syndrome. J Neurogastroenterol Motil (2011) 1.09
Prevalence and risk factors for abdominal bloating and visible distention: a population-based study. Gut (2008) 1.09
Biofeedback for pelvic floor dysfunction in constipation. BMJ (2004) 1.09
Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype. PLoS One (2012) 1.08
Slow transit constipation: a functional disorder becomes an enteric neuropathy. World J Gastroenterol (2006) 1.07
Evaluating breath methane as a diagnostic test for constipation-predominant IBS. Dig Dis Sci (2009) 1.06
Risk factors for onset of chronic oro-facial pain--results of the North Cheshire oro-facial pain prospective population study. Pain (2010) 1.06
The HTR3A polymorphism c. -42C>T is associated with amygdala responsiveness in patients with irritable bowel syndrome. Gastroenterology (2011) 1.05
Plain abdominal radiograph as an evaluation method of bowel dysfunction in patients with spinal cord injury. Ann Rehabil Med (2013) 1.05
Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS. Aliment Pharmacol Ther (2012) 1.05
Chronic constipation in hemiplegic patients. World J Gastroenterol (2007) 1.04
Studying the overlap between IBS and GERD: a systematic review of the literature. Dig Dis Sci (2006) 1.04
Sex-related differences of cortical thickness in patients with chronic abdominal pain. PLoS One (2013) 1.04
Epidemiology of Functional Gastrointestinal Disorders in Japan and in the World. J Neurogastroenterol Motil (2015) 1.04
Cross-cultural validation of Irritable Bowel Syndrome Quality of Life in Korea. Dig Dis Sci (2006) 1.04
Functional brain imaging in irritable bowel syndrome with rectal balloon-distention by using fMRI. World J Gastroenterol (2003) 1.03
Alteration of the spinal modulation of nociceptive processing in patients with irritable bowel syndrome. Gut (2004) 1.03
Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. World J Gastroenterol (2003) 1.03
Systematic investigation of gastrointestinal diseases in China (SILC): validation of survey methodology. BMC Gastroenterol (2009) 1.03
Multislice CT enteroclysis in the diagnosis of bowel endometriosis. Eur Radiol (2006) 1.03
Role of Cytolethal Distending Toxin in Altered Stool Form and Bowel Phenotypes in a Rat Model of Post-infectious Irritable Bowel Syndrome. J Neurogastroenterol Motil (2012) 1.02
Effectiveness and safety of herbal medicines in the treatment of irritable bowel syndrome: a systematic review. World J Gastroenterol (2008) 1.02
Effectiveness of laxatives in adults. Qual Health Care (2001) 1.02
Toward a definition of colonic inertia. World J Gastroenterol (2004) 1.02
Efficacy of biofeedback plus transanal stimulation in the management of pelvic floor dyssynergia: a randomized trial. Tech Coloproctol (2015) 1.01
Development and Validation of the Korean Rome III Questionnaire for Diagnosis of Functional Gastrointestinal Disorders. J Neurogastroenterol Motil (2013) 1.01
Evaluation of serum-derived bovine immunoglobulin protein isolate in subjects with diarrhea-predominant irritable bowel syndrome. Clin Med Insights Gastroenterol (2013) 1.01
Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome. J Clin Immunol (2009) 1.01
Towards positive diagnosis of the irritable bowel. Br Med J (1978) 12.79
The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases. Q J Med (1962) 8.19
U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci (1993) 7.98
A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance. N Engl J Med (1995) 5.02
Defecation frequency and timing, and stool form in the general population: a prospective study. Gut (1992) 3.17
Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ (1990) 2.86
Medical costs in community subjects with irritable bowel syndrome. Gastroenterology (1995) 2.81
Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology (1997) 2.71
A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology (1984) 2.70
The irritable bowel syndrome: mechanisms and a practical approach to management. Ann Intern Med (1992) 2.54
Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet (1987) 2.13
A longitudinal survey of self-reported bowel habits in the United States. Dig Dis Sci (1989) 2.08
The self-limited nature of chronic idiopathic diarrhea. N Engl J Med (1992) 1.73
Bowel habits in young adults not seeking health care. Dig Dis Sci (1987) 1.72
Radioisotope determination of regional colonic transit in severe constipation: comparison with radio opaque markers. Gut (1993) 1.71
Clinical response to dietary fiber treatment of chronic constipation. Am J Gastroenterol (1997) 1.61
Evidence for the ambiguity of the term constipation: the role of irritable bowel syndrome. Gut (1994) 1.44
Associations between symptoms of irritable colon and psychological and social conditions and lifestyle. Br Med J (Clin Res Ed) (1986) 1.44
Irritable bowel syndrome defined by factor analysis. Gender and race comparisons. Dig Dis Sci (1995) 1.41
Existence of irritable bowel syndrome supported by factor analysis of symptoms in two community samples. Gastroenterology (1990) 1.39
The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. J Intern Med (1994) 1.34
Gender differences in irritable bowel symptoms. Eur J Gastroenterol Hepatol (1997) 1.23
Contributions of evacuation proctography and anorectal manometry to evaluation of adults with constipation and defecatory difficulty. Dig Dis Sci (1990) 1.21
Effectiveness of an interdisciplinary pain management program for the treatment of chronic pelvic pain. Pain (1990) 1.12
Polyethylene glycol 4000 for slow transit constipation. Z Gastroenterol (1995) 1.11
Irritable bowel syndrome and chronic pelvic pain. Obstet Gynecol Surv (1994) 1.11
Chronic functional abdominal pain. Am J Gastroenterol (1996) 1.05
Irritable bowel syndrome. Diagnosis in the managed care era. Dig Dis Sci (1997) 1.00
Towards positive diagnosis of the irritable bowel. Br Med J (1978) 12.79
Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol (1997) 8.81
Functional bowel disorders in apparently healthy people. Gastroenterology (1980) 8.52
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90
The irritable bowel syndrome. Gastroenterology (1977) 4.64
Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med (1995) 4.56
Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology (1982) 4.46
A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology (1989) 4.27
Symptoms in gastro-oesophageal reflux disease. Lancet (1990) 4.10
Is extrinsic sugar a vehicle for dietary fat? Lancet (1995) 4.05
Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci (1998) 3.74
Irritable bowel syndrome: a multibillion-dollar problem. Gastroenterology (1995) 3.58
Effects of increased dietary fibre on intestinal transit. Lancet (1973) 3.49
Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut (2000) 3.26
Depletion and disruption of dietary fibre. Effects on satiety, plasma-glucose, and serum-insulin. Lancet (1977) 3.08
Diet and Crohn's disease: characteristics of the pre-illness diet. Br Med J (1979) 2.93
Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ (1990) 2.86
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med (2000) 2.78
Measurement of gastric functions during digestion of ordinary solid meals in man. Gastroenterology (1976) 2.56
Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci (2002) 2.46
Medical interviewing and interpersonal skills teaching in US medical schools. Progress, problems, and promise. JAMA (1993) 2.37
An epidemiological survey of constipation in canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol (2001) 2.30
Symptom complaints and health care seeking behavior in subjects with bowel dysfunction. Gastroenterology (1984) 2.24
Perceptions and reactions of the public to diarrhoea. J R Soc Health (1993) 2.22
Increasing frequency of gall bladder operations in the Bristol clinical area. Br Med J (1972) 2.20
Fecal weight, colon cancer risk, and dietary intake of nonstarch polysaccharides (dietary fiber) Gastroenterology (1992) 2.19
A critical review of epidemiological studies in inflammatory bowel disease. Scand J Gastroenterol (2001) 2.18
Gall stones in patients with disorders of the terminal ileum and disturbed bile salt metabolism. Br Med J (1969) 2.17
The effect of wheat bran on intestinal transit. Gut (1975) 2.10
The importance of keeping bile salts in their place. Gut (1969) 2.08
Effect of cholecystectomy on bowel function: a prospective, controlled study. Gut (1999) 2.08
The MD thesis in the training of a consultant physician. J R Coll Physicians Lond (1992) 2.03
Optimal thresholds, sensitivity, and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease. Gastroenterology (1987) 1.88
Food fibre as an obstacle to energy intake. Lancet (1973) 1.87
Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology (1987) 1.84
Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation. Aliment Pharmacol Ther (2012) 1.83
The epidemiology of gallstones and suggested aetiology. Clin Gastroenterol (1973) 1.83
Variability of colonic function in healthy subjects. Gut (1978) 1.82
Wheat fibre and irritable bowel syndrome. A controlled trial. Lancet (1977) 1.80
Predictors of duodenal ulcer healing and relapse. Gastroenterology (1981) 1.78
Esophageal 24-h pH monitoring: is prior manometry necessary for correct positioning of the electrode? Am J Gastroenterol (1990) 1.76
Sexual and physical abuse history in gastroenterology practice: how types of abuse impact health status. Psychosom Med (1996) 1.74
Selected symptoms associated with sexual and physical abuse history among female patients with gastrointestinal disorders: the impact on subsequent health care visits. Psychol Med (1998) 1.74
A national survey of practice patterns of gastroenterologists with comparison to the past two decades. J Clin Gastroenterol (1999) 1.73
Bowel habits in young adults not seeking health care. Dig Dis Sci (1987) 1.72
Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther (1999) 1.66
Intestinal transit, deoxycholic acid and the cholesterol saturation of bile--three inter-related factors. Gut (1986) 1.64
Smoking, sugar, and inflammatory bowel disease. Br Med J (Clin Res Ed) (1985) 1.64
Abdominal pain caused by diabetic radiculopathy. Ann Intern Med (1977) 1.63
Gallbladder inertia and sluggish enterohepatic circulation of bile-salts in coeliac disease. Lancet (1971) 1.62
Effect of dietary fiber on symptoms and rectosigmoid motility in patients with irritable bowel syndrome. A controlled, crossover study. Gastroenterology (1990) 1.62
Clinical response to dietary fiber treatment of chronic constipation. Am J Gastroenterol (1997) 1.61
Heartburn and globus in apparently healthy people. Can Med Assoc J (1982) 1.58
Three year follow up of patients with gastrooesophageal reflux disease. Gut (1992) 1.57
Esophageal tear caused by a tortilla chip. N Engl J Med (1990) 1.56
The effect of cholecystectomy on bile salt metabolism. Gut (1973) 1.56
Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome. Arch Intern Med (2001) 1.55
Gastric secretion and emptying after ordinary meals in duodenal ulcer. Gastroenterology (1977) 1.51
Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation. Aliment Pharmacol Ther (2008) 1.50
The effect on intestinal transit and the feces of raw and cooked bran in different doses. Am J Clin Nutr (1976) 1.50
The problem patient. Evaluation and care of medical patients with psychosocial disturbances. Ann Intern Med (1978) 1.49
Validity of the Family APGAR in patients with irritable bowel syndrome. Fam Med (1993) 1.45
Evidence for the ambiguity of the term constipation: the role of irritable bowel syndrome. Gut (1994) 1.44
Quality of life measurement in gastrointestinal and liver disorders. Gut (2000) 1.44
Bile salt metabolism in patients with gallstones in functioning gallbladders. Gut (1973) 1.39
Treatment of Crohn's disease with an unrefined-carbohydrate, fibre-rich diet. Br Med J (1979) 1.39
The reliability and validity of a sexual and physical abuse history questionnaire in female patients with gastrointestinal disorders. Behav Med (1995) 1.37
The effect of wheat bran upon bile salt metabolism and upon the lipid composition of bile in gallstone patients. Am J Dig Dis (1976) 1.36
Irritable bowel syndrome. Annu Rev Med (2001) 1.36
Enterohepatic circulation of C14-labeled bile salts in disorders of the distal small bowel. Gastroenterology (1968) 1.36
Postprandial gastric, pancreatic, and biliary response to histamine H2-receptor antagonists active duodenal ulcer. Gastroenterology (1977) 1.34
An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol (2003) 1.34
The role of dietary fiber in satiety, glucose, and insulin: studies with fruit and fruit juice. Am J Clin Nutr (1981) 1.32
Irritable bowel syndrome: the view from general practice. Eur J Gastroenterol Hepatol (1997) 1.32
How trustworthy are bowel histories? Comparison of recalled and recorded information. Br Med J (1976) 1.29
Cimetidine suppression of nocturnal gastric secretion in active duodenal ulcer. N Engl J Med (1976) 1.29
Urgency and fecal soiling in people with bowel dysfunction. Dig Dis Sci (1986) 1.27
Recurrence and re-recurrence of gall stones after medical dissolution: a longterm follow up. Gut (1988) 1.26
Impact of sexual and physical abuse dimensions on health status: development of an abuse severity measure. Psychosom Med (1997) 1.26
Deoxycholic acid and the pathogenesis of gall stones. Gut (1988) 1.26
Increasing butyrate concentration in the distal colon by accelerating intestinal transit. Gut (1997) 1.25
Novel approach to quantify duodenogastric reflux in healthy volunteers and in patients with type I gastric ulcer. Gut (1983) 1.25
Miliary Crohn's disease. Gut (1967) 1.24
What is behind dyspepsia? Dig Dis Sci (1993) 1.23
Diet and ulcerative colitis. Br Med J (1980) 1.20
When is esophagitis healed? esophageal endoscopy, histology and function before and after cimetidine treatment. Dig Dis Sci (1982) 1.20
Extrahepatic portal hypertension caused by chronic pancreatitis. Ann Intern Med (1971) 1.20
Quality of life in inflammatory bowel disease. J Clin Gastroenterol (1992) 1.19
Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation. Neurogastroenterol Motil (2014) 1.19
Gastrointestinal illness and the biopsychosocial model. J Clin Gastroenterol (1996) 1.19
Proctalgia fugax. J R Coll Physicians Lond (1980) 1.18
Utility of red flag symptom exclusions in the diagnosis of irritable bowel syndrome. Aliment Pharmacol Ther (2006) 1.17
Healthy controls have as much bile reflux as gastric ulcer patients. Gut (1987) 1.17
Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease. Am J Gastroenterol (2001) 1.16
Quality of life in patients with inflammatory bowel disease. J Clin Gastroenterol (1988) 1.15
Psyllium therapy in the irritable bowel syndrome. A double-blind trial. Ann Intern Med (1981) 1.15
Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis. Gut (1997) 1.14
Effects of a new, concentrated wheat fibre preparation on intestinal transit, deoxycholic acid metabolism and the composition of bile. Gut (1986) 1.14
Aetiology of acute appendicitis. Br Med J (Clin Res Ed) (1987) 1.14